The need to optimize adolescent immunization
HH Bernstein, JA Bocchini, CL Byington… - …, 2017 - publications.aap.org
Clinical reports from the American Academy of Pediatrics benefit from expertise and
resources of liaisons and internal (AAP) and external reviewers. However, clinical reports …
resources of liaisons and internal (AAP) and external reviewers. However, clinical reports …
[HTML][HTML] From the monovalent to the nine-valent HPV vaccine
S Pils, EA Joura - Clinical Microbiology and Infection, 2015 - Elsevier
An investigational monovalent human papillomavirus (HPV) 16 virus-like particle vaccine
has been shown to prevent persistent infection and cervical disease related to HPV 16 and …
has been shown to prevent persistent infection and cervical disease related to HPV 16 and …
Looking ahead: Caregivers' COVID-19 vaccination intention for children 5 years old and younger using the health belief model
COVID-19 vaccine hesitancy is a significant public health issue. While vaccines are not yet
available for children, clinical trials are underway, and children will likely be an important …
available for children, clinical trials are underway, and children will likely be an important …
The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: results and reflections
T Byers, RC Wender, A Jemal… - CA: a cancer journal …, 2016 - Wiley Online Library
Abstract In 1996, the Board of Directors of the American Cancer Society (ACS) challenged
the United States to reduce what looked to be possible peak cancer mortality in 1990 by …
the United States to reduce what looked to be possible peak cancer mortality in 1990 by …
Parental perceptions of the COVID-19 vaccine for 5-to 11-year-old children: Focus group findings from Worcester Massachusetts
M Goulding, GW Ryan, P Minkah, A Borg… - Human Vaccines & …, 2022 - Taylor & Francis
Vaccine hesitancy is a long-standing public health issue. The present work describes
parental perceptions of COVID-19 vaccination for 5-to 11-year-old children, to aid in …
parental perceptions of COVID-19 vaccination for 5-to 11-year-old children, to aid in …
Coadministration of a 9-valent human papillomavirus vaccine with meningococcal and Tdap vaccines
A Schilling, MM Parra, M Gutierrez, J Restrepo… - …, 2015 - publications.aap.org
BACKGROUND: This study in 11-to 15-year-old boys and girls compared the
immunogenicity and safety of GARDASIL 9 (9-valent human papillomavirus [9vHPV] …
immunogenicity and safety of GARDASIL 9 (9-valent human papillomavirus [9vHPV] …
Understanding the role of the news media in HPV vaccine uptake in the United States: Synthesis and commentary
Vaccination rates for the human papillomavirus (HPV) vaccine fall below targets and only 2
states and the District of Columbia require the vaccine for middle school-age children …
states and the District of Columbia require the vaccine for middle school-age children …
Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance
JS Bratic, ER Seyferth… - Current opinion in …, 2016 - journals.lww.com
Recent publications reveal new information about the implementation of HPV vaccines.
Provider recommendation is a key approach, as is offering it routinely at the same time as …
Provider recommendation is a key approach, as is offering it routinely at the same time as …
Cost-effectiveness of interventions to increase HPV vaccine uptake
OBJECTIVES: We sought to prioritize interventions for increasing human papillomavirus
(HPV) vaccination coverage based on cost-effectiveness from a US state perspective to …
(HPV) vaccination coverage based on cost-effectiveness from a US state perspective to …
[HTML][HTML] Vaccines against human papillomavirus infections: protection against cancer, genital warts or both?
EA Joura, S Pils - Clinical Microbiology and Infection, 2016 - Elsevier
Since 2006, three vaccines against infections and disease caused by human papillomavirus
(HPV) became available in Europe—in 2006 a quadrivalent HPV 6/11/16/18 vaccine, in …
(HPV) became available in Europe—in 2006 a quadrivalent HPV 6/11/16/18 vaccine, in …